Literature DB >> 20383206

Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.

T Tachibana, H Takasaki, M Tanaka, A Maruta, R Hyo, Y Ishigatsubo, H Kanamori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20383206     DOI： 10.1038/bmt.2010.62

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.

Authors:  M Tanaka; H Kanamori; K Matsumoto; T Tachibana; A Numata; K Ohashi; T Kobayashi; C Nakaseko; Y Kanda; E Yamazaki; S Fujisawa; J Ooi; T Sakura; N Aotsuka; M Onoda; S Machida; J Kato; K Usuki; R Watanabe; J Taguchi; S Yano; T Saito; S Takahashi; H Sakamaki; S Okamoto
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

2.  Prognostic impact of pretransplantation hyperferritinemia in adults undergoing allogeneic hematopoietic SCT: a meta-analysis.

Authors:  Z Wang; M Jia; H Zhao; Y Cheng; Z Luo; Y Chen; X Xu; Y Tang
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483

3.  The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.

Authors:  Yuan Yang; Zengwei Tang; Tianli An; Li Zhao
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.